Safety evaluation of ILaris: a real-world analysis of adverse events based on the FAERS database
It is critical for healthcare professionals to closely monitor patients for symptoms (such as pulmonary thrombosis, Hepatomegaly, Blood Lactate Dehydrogenase Increased, Splenomegaly, Appendicitis) and other adverse events during treatment.
Authors
- Yingjie Li (ORCID: https://orcid.org/0000-0003-4713-8755)
- Xun Yi (ORCID: https://orcid.org/0000-0001-7351-5724)
- He He (ORCID: https://orcid.org/0000-0002-9118-2449)
- Shujie Wu (ORCID: https://orcid.org/0000-0001-5866-1504)
Institutions
- University of Electronic Science and Technology of China (CN)
- Chengdu University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-02-22
- DOI
- https://doi.org/10.1080/14740338.2025.2465864
- Citations
- 1
- Primary Topic
- Risk and Safety Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.40